SCHWARTZ, PETER
 Distribuzione geografica
Continente #
NA - Nord America 16.635
AS - Asia 13.296
EU - Europa 11.339
SA - Sud America 1.536
AF - Africa 200
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 20
Totale 43.069
Nazione #
US - Stati Uniti d'America 16.342
CN - Cina 8.310
SG - Singapore 2.728
IE - Irlanda 2.597
UA - Ucraina 2.021
DE - Germania 1.755
HK - Hong Kong 1.317
BR - Brasile 1.260
FI - Finlandia 1.187
RU - Federazione Russa 1.095
SE - Svezia 899
IT - Italia 784
GB - Regno Unito 528
VN - Vietnam 342
CA - Canada 197
FR - Francia 179
IN - India 126
AR - Argentina 105
BD - Bangladesh 86
MX - Messico 65
JP - Giappone 64
IQ - Iraq 55
ZA - Sudafrica 55
NL - Olanda 52
EC - Ecuador 49
AT - Austria 48
BE - Belgio 45
ES - Italia 39
PL - Polonia 38
MA - Marocco 37
TR - Turchia 32
CO - Colombia 31
MU - Mauritius 31
PK - Pakistan 27
AU - Australia 25
ID - Indonesia 25
VE - Venezuela 25
KE - Kenya 23
PY - Paraguay 23
IR - Iran 21
JO - Giordania 20
CL - Cile 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
EU - Europa 17
NZ - Nuova Zelanda 16
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 13
EG - Egitto 13
PE - Perù 10
DZ - Algeria 9
NP - Nepal 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
IL - Israele 8
OM - Oman 8
AL - Albania 7
LT - Lituania 7
LV - Lettonia 7
TN - Tunisia 7
BG - Bulgaria 6
BO - Bolivia 6
CR - Costa Rica 6
DK - Danimarca 6
SN - Senegal 6
CH - Svizzera 5
HU - Ungheria 5
KR - Corea 5
KW - Kuwait 5
KZ - Kazakistan 5
RO - Romania 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
MY - Malesia 4
NI - Nicaragua 4
PH - Filippine 4
PS - Palestinian Territory 4
BH - Bahrain 3
BW - Botswana 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
NO - Norvegia 3
PA - Panama 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AM - Armenia 2
CG - Congo 2
GA - Gabon 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PR - Porto Rico 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 43.044
Città #
Chandler 2.644
Dublin 2.592
Jacksonville 2.590
Nanjing 2.101
Dallas 1.468
Hong Kong 1.311
Ashburn 1.156
Singapore 1.080
Beijing 946
Boardman 901
Nanchang 853
Princeton 640
Lawrence 603
Shenyang 600
Changsha 575
Hebei 571
Wilmington 559
Jiaxing 511
Munich 482
Helsinki 422
Medford 408
Los Angeles 348
Tianjin 331
Hangzhou 324
Moscow 232
Redondo Beach 224
Buffalo 202
Ann Arbor 195
Milan 148
Woodbridge 148
New York 138
Shanghai 130
Ho Chi Minh City 117
São Paulo 116
Verona 115
Norwalk 112
Toronto 74
Hanoi 69
Houston 69
Nuremberg 63
Seattle 63
Tokyo 62
Fairfield 61
Kunming 58
Pavia 53
Zhengzhou 53
Guangzhou 52
Mcallen 52
Brooklyn 51
Des Moines 47
Washington 47
Falkenstein 44
Jinan 44
Falls Church 42
Chicago 40
San Francisco 39
Montréal 37
Ningbo 36
Brussels 35
Warsaw 35
Johannesburg 32
Santa Clara 32
Turku 32
Boston 30
Rome 30
Stockholm 30
Chennai 29
Montreal 29
Rio de Janeiro 29
The Dalles 29
Baghdad 28
Belo Horizonte 28
Brasília 27
London 27
Denver 26
Orem 25
Fuzhou 24
Atlanta 23
Curitiba 23
Dearborn 23
Nairobi 21
Phoenix 21
Secaucus 21
Vienna 21
Amman 20
Mexico City 20
Pune 20
Changchun 19
Columbus 19
Frankfurt am Main 19
Lanzhou 19
Manchester 19
Charlotte 18
Guayaquil 18
Orange 18
Taizhou 18
Tashkent 18
San Genesio Ed Uniti 17
Tappahannock 17
Fortaleza 16
Totale 28.054
Nome #
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 286
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 252
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. 245
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. 241
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 240
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 236
Calcio antagonisti e aritmie da riperfusione miocardica 196
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 146
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 139
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 138
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 138
[Infant mortality and sudden crib death in Lombardy]. 129
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 126
Long QT and short QT syndromes. 126
[Neonatal electrocardiography and the sudden infant death syndrome (SIDS)]. 122
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 122
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 120
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 120
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 119
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. 118
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 118
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 117
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 116
[Cardio-cardiac sympathico-vagal reflex]. 115
FGF12 is a candidate Brugada syndrome locus. 115
[Sympathetic reflex induced by experimental coronary occlusion]. 114
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 114
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 113
Effect of Considering the Relatives' Quality of Life in Cost-Utility Studies 113
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 110
Alpha 1-adrenergic blockade and sudden cardiac death. 109
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 107
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 106
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 105
[Neural mechanisms of sudden death]. 105
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 104
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 102
Risk stratification in the Long-QT Syndrome 102
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 102
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 102
Long QT syndrome-associated mutations in intrauterine fetal death. 102
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 102
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 101
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 100
Mortalità infantile e morte improvvisa in culla in Lombardia 100
Inherited cardiac arrhythmia syndrome. Role of potassium channels 99
QT lungo, sindrome del 99
Cardiac potassium channel dysfunction in sudden infant death syndrome. 99
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 98
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 98
QT prolongation and sudden infant death syndrome - from theory to evidence. 98
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 98
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 98
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 98
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 98
All LQT3 patients need an ICD. True or false? 97
An experimental approach to the choice of antiarrhythmic therapy. 97
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 97
A Recessive Variant of the Romano-Ward Long QT Syndrome 96
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 96
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 96
Unexplained cardiac arrest. The need for a prospective registry. 96
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. 96
Cardiac sodium channel dysfunction in sudden infant death syndrome. 95
Adrenergic Arrhythmogenesis and The Long QT syndrome 95
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 95
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 94
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 94
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 93
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 93
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 93
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 93
[Long-QT caused by drugs and torsade de pointes: a genetic basis?]. 92
Can a message from the dead save lives? 92
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 92
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 92
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 91
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 91
Autonomic nervous system and arrhythmias. 91
A molecular basis for the therapy of the long QT syndrome 91
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 91
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 90
The ICD for the long QT syndrome: which indications, complications, and results? 90
The long QT syndrome. Prospective longitudinal study of 328 families. 90
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 90
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 90
Prevalence of the congenital long-QT syndrome. 90
The genetics underlying acquired long QT syndrome: impact for genetic screening. 90
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 89
Sertraline treatment of major depression in patients with acute MI or unstable angina. 89
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 89
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 89
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 88
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 88
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 88
[Electric change of the wave T: clinical and experimental evidence of its relation to the sympathetic nervous system]. 88
Congenital long QT and short QT syndromes 88
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 88
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 88
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 88
Totale 11.165
Categoria #
all - tutte 184.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.355 0 0 0 0 0 486 11 569 117 560 503 109
2021/20222.401 31 10 72 28 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.416 259 528 108 197 280 647 52 128 7 67 69 74
2024/20257.226 120 683 194 251 110 284 617 756 1.604 222 627 1.758
2025/20268.093 1.114 1.197 2.185 1.436 1.632 529 0 0 0 0 0 0
Totale 43.353